Open Journal of Endocrine and Metabolic Diseases
Vol.8 No.8(2018), Paper ID 89038, 10
pages
DOI:10.4236/ojemd.2018.88016
Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® with Reference Product— Lantus®: Study Protocol & Early Data Trends
S. K. Sharma, A. K. Ajmani, P. Khosla, P. Mukhopadhyay, G. Bhatia, K. G. Prakash, G. Chhaya, P. D. Supe, V. Pavithran, H. Bora, R. Jain, S. Ingole, A. Shah
Diabetes, Thyroid and Endocrine Centre, Jaipur, India
BL Kapoor Hospital, Delhi, India
Sir Ganga Ram Hospital, Delhi, India
Institute of Post Graduate Medical Education and Research, Kolkata, India
Medipoint Hospitals Pvt. Ltd., Pune, India
Bangalore Medical College and Research Institute, Bangalore, India
Sanjivani Supers Peciality Hospital, Ahmedabad, India
Supe Heart and Diabetes Hospital and Research Centre, Nashik, India
KVM Hospital, Kerala, India
Downtown Hospital, Guwahati, India
Wockhardt Ltd., Mumbai, India
Wockhardt Ltd., Mumbai, India
Wockhardt Ltd., Mumbai, India
Copyright © 2018 S. K. Sharma, A. K. Ajmani, P. Khosla, P. Mukhopadhyay, G. Bhatia, K. G. Prakash, G. Chhaya, P. D. Supe, V. Pavithran, H. Bora, R. Jain, S. Ingole, A. Shah et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Sharma, S. , Ajmani, A. , Khosla, P. , Mukhopadhyay, P. , Bhatia, G. , Prakash, K. , Chhaya, G. , Supe, P. , Pavithran, V. , Bora, H. , Jain, R. , Ingole, S. and Shah, A. (2018) Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® with Reference Product— Lantus®: Study Protocol & Early Data Trends.
Open Journal of Endocrine and Metabolic Diseases,
8, 157-166. doi:
10.4236/ojemd.2018.88016.